Have a personal or library account? Click to login
Complexation of Z-ligustilide with hydroxypropyl-β-cyclodextrin to improve stability and oral bioavailability Cover

Complexation of Z-ligustilide with hydroxypropyl-β-cyclodextrin to improve stability and oral bioavailability

By: Yapeng Lu,  Siyuan Liu,  Yu Zhao,  Li Zhu and  Shuqin Yu  
Open Access
|Jun 2014

References

  1. 1. H. Y. Peng, J. R. Du, G. Y. Zhang, X. Kuang, Y. X. Liu, Z. M. Qian and C. Y. Wang, Neuroprotective effect of Z-ligustilide against permanent focal ischemic damage in rats, Biol. Pharm. Bull. 30 (2007) 309-312; DOI: JST.JSTAGE/bpb/30.309 [pii].10.1248/bpb.30.309
  2. 2. J. Sun, B. K. Tan, S. H. Huang, M. Whiteman and Y. Z. Zhu, Effects of natural products on ischemic heart diseases and cardiovascular system, Acta Pharmacol. Sin. 23(2002) 1142-1151.
  3. 3. J. Y. Zhan, K. Y. Zheng, K. Y. Zhu, C. W. Bi, W. L. Zhang, C. Y. Du, Q. Fu, T. T. Dong, R. C. Choi, K. W. Tsim and D. T. Lau, Chemical and biological assessment of Angelicae Sinensis Radix after processing with wine: an orthogonal array design to reveal the optimized conditions, J. Agric Food Chem. 59 (2011) 6091-6098; DOI: 10.1021/jf200728e.10.1021/jf200728e
  4. 4. K. Y. Zheng, R. C. Choi, A. W. Cheung, A. J. Guo, C. W. Bi, K. Y. Zhu, Q. Fu, Y. Du, W. L. Zhang, J. Y. Zhan, R. Duan, D. T. Lau, T. T. Dong and K. W. Tsim, Flavonoids from Radix Astragali induce the expression of erythropoietin in cultured cells: a signaling mediated via the accumulation of hypoxia-inducible factor-1alpha, J. Agric. Food Chem. 59 (2011) 1697-1704; DOI: 10.1021/ jf104018u.
  5. 5. X. M. Wu, Z. M. Qian, L. Zhu, F. Du, W. H. Yung, Q. Gong and Y. Ke, Neuroprotective effect of ligustilide against ischemia-reperfusion injury via up-regulation of erythropoietin and down- -regulation of RTP801, Br. J. Pharmacol. 164 (2011) 332-343; DOI: 10.1111/j.1476-5381.2011. 01337.x.
  6. 6. X. Kuang, J. R. Du, Y. X. Liu, G. Y. Zhang and H. Y. Peng, Postischemic administration of Z-ligustilide ameliorates cognitive dysfunction and brain damage induced by permanent forebrain ischemia in rats, Pharmacol. Biochem. Behav. 88 (2008) 213-221; DOI: 10.1016/j.pbb.2007. 08.006.
  7. 7. X. Kuang, J. R. Du, Y. S. Chen, J. Wang and Y. N. Wang, Protective effect of Z-ligustilide against amyloid beta-induced neurotoxicity is associated with decreased pro-inflammatory markers in rat brains, Pharmacol. Biochem. Behav. 92 (2009) 635-641; DOI: 10.1016/j.pbb.2009.03.007.10.1016/j.pbb.2009.03.007
  8. 8. F. Cui, L. Feng and J. Hu, Factors affecting stability of z-ligustilide in the volatile oil of radix angelicae sinensis and ligusticum chuanxiong and its stability prediction, Drug Dev. Ind. Pharm. 32 (2006) 747-755; DOI: 10.1080/03639040500529101.10.1080/03639040500529101
  9. 9. S. Pinnamaneni, N. G. Das and S. K. Das, Formulation approaches for orally administered poorly soluble drugs, Pharmazie 57 (2002) 291-300.
  10. 10. J. Szejtli, Introduction and general overview of cyclodextrin chemistry, Chem. Rev. 98 (1998) 1743-1754; DOI: cr970022c [pii].10.1021/cr970022c
  11. 11. L. Szente and J. Szejtli, Highly soluble cyclodextrin derivatives: chemistry, properties, and trends in development, Adv. Drug Deliv. Rev. 36 (1999) 17-28; DOI: S0169-409X(98)00092-1 [pii].10.1016/S0169-409X(98)00092-1
  12. 12. S. Gould and R. C. Scott, 2-Hydroxypropyl-beta-cyclodextrin (HP-beta-CD): a toxicology review, Food Chem. Toxicol. 43 (2005) 1451-1459; DOI: 10.1016/j.fct.2005.03.007.10.1016/j.fct.2005.03.00716018907
  13. 13. G. E. Granero, M. M. Maitre, C. Garnero and M. R. Longhi, Synthesis, characterization and in vitro release studies of a new acetazolamide-HP-beta-CD-TEA inclusion complex, Eur. J. Med. Chem. 43 (2008) 464-470; DOI: 10.1016/j.ejmech.2007.03.037.10.1016/j.ejmech.2007.03.03717544174
  14. 14. B. Yang, J. Lin, Y. Chen and Y. Liu, Artemether/hydroxypropyl-beta-cyclodextrin host-guest system: characterization, phase-solubility and inclusion mode, Bioorg. Med. Chem. 17 (2009) 6311-6317; DOI: 10.1016/j.bmc.2009.07.060.10.1016/j.bmc.2009.07.06019665897
  15. 15. C. Yuan, Z. Y. Jin, X. M. Xu, H. N. Zhuang and W. Y. Shen, Preparation and stability of the inclusion complex of astaxanthin with hydroxypropyl-beta-cyclodextrin, Food Chem. 109 (2008) 264-268; DOI: 10.1016/j.foodchem.2007.07.051.10.1016/j.foodchem.2007.07.05126003346
  16. 16. Y. Yu, J. R. Du, C. Y. Wang and Z. M. Qian, Protection against hydrogen peroxide-induced injury by Z-ligustilide in PC12 cells, Exp. Brain Res. 184 (2008) 307-312; DOI: 10.1007/s00221-007- -1100-3.
  17. 17. Q. F. Zhang, Z. T. Jiang, Y. X. Guo and R. Li, Complexation study of brilliant cresyl blue with beta-cyclodextrin and its derivatives by UV-vis and fluorospectrometry, Spectrochim. Acta A Mol. Biomol. Spectrosc. 69 (2008) 65-70; DOI: 10.1016/j.saa.2007.03.009.10.1016/j.saa.2007.03.00917433764
  18. 18. L. M. Pinto, L. F. Fraceto, M. H. Santana, T. A. Pertinhez, S. O. Junior and de E. Paula, Physico- -chemical characterization of benzocaine-beta-cyclodextrin inclusion complexes, J. Pharm. Biomed. Anal. 39 (2005) 956-963; DOI: 10.1016/j.jpba.2005.06.010.10.1016/j.jpba.2005.06.01016040222
  19. 19. X. Ge, Z. Huang, S. L. Tian, Y. L. Huang and C. Z. Zeng, Complexation of carbendazim with hydroxypropyl-beta-cyclodextrin to improve solubility and fungicidal activity, Carbohyd. Polym. 89 (2012) 208-212; DOI: 10.1016/j.carbpol.2012.02.072.10.1016/j.carbpol.2012.02.07224750625
  20. 20. P. Gornas, G. Neunert, K. Baczynski and K. Polewski, Beta-cyclodextrin complexes with chlorogenic and caffeic acids from coffee brew: Spectroscopic, thermodynamic and molecular modelling study, Food Chem. 114 (2009) 190-196; DOI: 10.1016/j.foodchem.2008.09.048.10.1016/j.foodchem.2008.09.048
  21. 21. D. R. de Araujo, S. S. Tsuneda, C. M. S. Cereda, F. Del G. F. Carvalho, P. S. C. Preté, S. A. Fernandes, F. Yokaichiya, M. K. K. D. Franco, I. Mazzaro, L. F. Fraceto, A.de F. A. Braga and E. de Paula, Development and pharmacological evaluation of ropivacaine-2-hydroxypropyl-beta- -cyclodextrin inclusion complex, Eur. J. Pharm. Sci. 33 (2008) 60-71; DOI: 10.1016/j.ejps.2007. 09.010.
  22. 22. P. Mura, E. Adragna, A. M. Rabasco, J. R. Moyano, J. I. Perez-Martinez, A. J. Arias and J. M. Gines, Effects of the host cavity size and the preparation method on the physicochemical properties of ibuproxam-cyclodextrin systems, Drug Dev. Ind. Pharm. 25 (1999) 279-287; DOI: 10.1081/ DDC-100102172.10.1081/DDC-100102172
  23. 23. E. E. M. Eid, A. B. Abdul, F. E. O. Suliman, M. A. Sukari, A. Rasedee and S. S. Fatah, Characterization of the inclusion complex of zerumbone with hydroxypropyl-beta-cyclodextrin, Carbohyd. Polym. 83 (2011) 1707-1714; DOI: 10.1016/j.carbpol.2010.10.033.10.1016/j.carbpol.2010.10.033
  24. 24. Y. Y. Hwang, D. C. Shin, Y. S. Nam and B. K. Cho, Characterization, stability, and pharmacokinetics of sibutramine/beta-cyclodextrin inclusion complex, J. Ind. Eng. Chem. 18 (2012) 1412-1417; DOI: 10.1016/j.jiec.2012.01.046.10.1016/j.jiec.2012.01.046
  25. 25. R. Yan, N. L. Ko, S. L. Li, Y. K. Tam and G. Lin, Pharmacokinetics and metabolism of ligustilide, a major bioactive component in Rhizoma Chuanxiong, in the rat, Drug Metab. Dispos. 36 (2008) 400-408; DOI: 10.1124/dmd.107.017707. 10.1124/dmd.107.01770718039808
DOI: https://doi.org/10.2478/acph-2014-0012 | Journal eISSN: 1846-9558 | Journal ISSN: 1330-0075
Language: English
Page range: 211 - 222
Accepted on: Dec 12, 2013
|
Published on: Jun 6, 2014
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year
Related subjects:

© 2014 Yapeng Lu, Siyuan Liu, Yu Zhao, Li Zhu, Shuqin Yu, published by Croatian Pharmaceutical Society
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.